4th Quarter - Report

MEHLMAN CONSULTING, INC. for MAYO CLINIC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General healthcare; health reform; healthcare value and quality; health information technology; clinical trials; tele-health; healthcare costs; healthcare interoperability. Promoting biomedical research. Opioid addiction and treatment. Rural health.

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

General healthcare; health reform; healthcare value and quality; health information technology; clinical trials; tele-health; healthcare costs; healthcare interoperability. Promoting biomedical research. Opioid addiction and treatment. S. 1895: Lower Health Care Costs Act. Patent issues impacting clinical laboratory innovation. H.R. 1865 - Further Consolidated Appropriations Act, 2020

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1895 (116th), H.R. 1865 (116th)

Veterans VET

Reimbursement issues.

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.